Award of lynntech's DHA 18.3 (a) sbir phase II from proposal H2-0542 for "rapid at-home test for monitoring tacrolimus levels in blood"

Ended Definitive Contract Awarded Last action

Contract number
W81XWH20C0057
Awardee
Awarding agency
Obligated
$1,099,983

Award facts

Opportunity
  • HQ003418R3ADB Solicitation number
Contract value 100% obligated
$1,099,983.19 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
College Station, TX, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00008 $0
Other Administrative Action P00007 · DHA sbir 18.3 (a) phase II - H2-0542 $0
Supplemental Agreement for work within scope P00006 · 9 month no cost extension. Per section 711 of the 2019 ndaa, usamraa transferred to DHA 10/01/2022. $0
Supplemental Agreement for work within scope P00005 · Principal investigator change to the award of lynntech's DHA sbir phase II medical r & d contract for "rapid at-home test for monitoring tacrolimus levels in… $0
Supplemental Agreement for work within scope P00004 · No-cost extension to the award of lynntech's DHA sbir phase II medical r & d contract for "rapid at-home test for monitoring tacrolimus levels in blood" $0
Other Administrative Action P00003 · COR change to the award of lynntech's DHA sbir phase II medical r & d contract for "rapid at-home test for monitoring tacrolimus levels in blood" $0
Supplemental Agreement for work within scope P00002 · COR change and clause and language update to the award of lynntech's DHA sbir phase II medical r & d contract for "rapid at-home test for monitoring… $0
Supplemental Agreement for work within scope P00001 · Clause updates to the award of lynntech's DHA sbir phase II medical r & d contract for "rapid at-home test for monitoring tacrolimus levels in blood" $0
Original award $1,099,983

About this award

This is a $1,099,983.19 Definitive Contract awarded by the Defense Health Agency (DHA) to Lynntech Inc., a small business, under the SBIR Program Phase II. The contract is for Lynntech's "Rapid At-Home Test for Monitoring Tacrolimus Levels in Blood", which was proposed under solicitation H2-0542. The contract is set aside for small businesses and has a completion date of August 5, 2024. Lynntech is a small business that provides research, development, testing, and evaluation services to various U.S. federal government agencies, including the Department of Defense, NASA, NIH, DHS, and NOAA, through prime and subcontract awards, often in the form of SBIR and STTR grants and contracts.

Quick answers

Who was awarded contract W81XWH20C0057?

W81XWH20C0057 was awarded to Lynntech Inc. by Defense Health Agency (Department of Defense) on July 6, 2020.

How much is contract W81XWH20C0057 worth?

The government has obligated $1,099,983 on W81XWH20C0057.

Was contract W81XWH20C0057 competed?

The extent of competition for W81XWH20C0057 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award